The interventional therapeutic effect and prognosis of the diffuse type HCC are the worst than that of other type primary hepatic carcinoma.
弥漫型肝癌的介入治疗效果及预后远较其他类型原发型肝癌差。
Conclusion Serum CRP can not be used as a marker for HCC, but very high levels of CRP in patients with cirrhosis may suggest the presence of diffuse type HCC.
结论血清CRP不能作为肝癌的标志，但是肝硬化患者CRP水平很高时可提示存在弥漫型肝癌。
应用推荐